Opioid Use Disorder
5 competing products in clinical development for Opioid Use Disorder.
Pipeline by Phase
Phase 12
Phase 21
Phase 32
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| SUBLOCADE | Indivior PLC | Phase 3 | Withdrawn | 29 |
| SUBLOCADE | Indivior PLC | Phase 3 | Terminated | 29 |
| ASP8082 + morphine + Placebo | Astellas Pharma | Phase 1 | Completed | 29 |
| ASP8062 + Placebo ASP8062 + buprenorphine/naloxone | Astellas Pharma | Phase 1 | Completed | 29 |
| ASP8062 + Placebo ASP8062 + buprenorphine/naloxone | Astellas Pharma | Phase 2 | Withdrawn | 27 |